Mergers & Acquisitions Mergers & Acquisitions

Sigma-Aldrich gets new EU charges over false information in merger review (update*)

By Lewis Crofts
  • 01 Jul 2020 06:43
  • 01 Jul 2020 07:47
German biotech company Sigma-Aldrich is the target of additional charges over alleged false information submitted to EU officials during a merger deal involving Merck KGaA.

The European Commission said today it had issued a supplementary Statement of Objections, replacing a 2017 charge sheet to focus just on Sigma (see here).

Merck won EU approval

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Lewis Crofts

Editor-In-Chief


Lewis leads MLex's editorial strategy, content direction, quality and development. He has a reputation for breaking stories and providing analysis on complex legal disputes before regulators and courts around the globe. He has also developed MLex's unrivalled coverage of competition policy, litigation, regulation, Brexit and international investigations.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News